FAMHP (Belgian Medicine Agency) · September 01, 2026

New Marketing Authorisation Application Form (eAF) version 1.28.0.0 for national, mutual recognition and decentralised procedures

Original title: From 1 September 2026: new Marketing Authorisation Application Form for national, mutual recognition and decentralised procedures

From 1 September 2026, applicants must use new eAF version 1.28.0.0, aligned with ISO IDMP model and Veterinary Regulation 2019/6.

High obligation Framework Pharmaceuticals BelgiumEU-wide Pharmaceuticals

Applicants and marketing authorisation holders can now use the new version (1.28.0.0) of the Marketing Authorisation Application Form for national, mutual recognition and decentralised procedures. From 1 September 2026, thenew version of the Marketing Authorisation Application Form (eAF)may be used. The main purpose of this update is to align product data in the application form with the ISO Identification of Medicinal Products (IDMP) model. For veterinary medicinal products, the update also reflects changes related to theNew Veterinary Regulation 2019/6(NVR). Human medicinal productsFor human medicinal products, the new version of the eAF may be used for new marketing authorisation applications submitted to national competent authorities

Dates and deadlines

Applies from

2026-09-01

Regulatory Deadline

September 01, 2026

Read the official source ↗

Published by FAMHP (Belgian Medicine Agency). HealthSignal links to the original document; the summary above is extracted from the source text.